# Low Dose Morphine to Relieve Dyspnea in Acute Respiratory Failure (OPIDYS)

> **NCT04358133** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 23 (actual)

## Conditions studied

- Acute Respiratory Failure

## Interventions

- **DRUG:** Chlorhydrate de morphine
- **DRUG:** NaCl 0,9%,

## Key facts

- **NCT ID:** NCT04358133
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-16
- **Primary completion:** 2022-10-07
- **Final completion:** 2022-10-07
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04358133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04358133, "Low Dose Morphine to Relieve Dyspnea in Acute Respiratory Failure (OPIDYS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04358133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*